Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Manganese enhanced magnetic resonance imaging of normal and ischemic canine heart.

Hu TC, Christian TF, Aletras AH, Taylor JL, Koretsky AP, Arai AE.

Magn Reson Med. 2005 Jul;54(1):196-200.

PMID:
15968667
2.

Determining canine myocardial area at risk with manganese-enhanced MR imaging.

Natanzon A, Aletras AH, Hsu LY, Arai AE.

Radiology. 2005 Sep;236(3):859-66.

PMID:
16118166
3.

Quantification of area at risk during coronary occlusion and reperfusion by means of MR perfusion imaging.

Szolar DH, Saeed M, Wendland M, Sakuma H, Stiskal MA, Derugin N, Higgins CB.

Acta Radiol. 1997 Jul;38(4 Pt 1):479-88.

PMID:
9240664
4.

Use of coronary anatomy and late enhancement information both derived from contrast-enhanced whole-heart coronary MRA at 3 T for the assessment of ischemic left ventricular dysfunction.

Liu Z, Yang Q, Zhao Y, Jin L, Jerecic R, Xu D, Li K, Hua Q.

Clin Imaging. 2011 May-Jun;35(3):222-4. doi: 10.1016/j.clinimag.2010.04.001.

PMID:
21513861
5.

Agreement of left ventricular mass in steady state free precession and delayed enhancement MR images: implications for quantification of fibrosis in congenital and ischemic heart disease.

Stephensen SS, Carlsson M, Ugander M, Engblom H, Olivecrona G, Erlinge D, Arheden H.

BMC Med Imaging. 2010 Jan 24;10:4. doi: 10.1186/1471-2342-10-4.

6.

Early detection of myocardial infarction with magnetic resonance imaging in a canine model.

Angelos MG, Katz-Stein A, Leasure JE.

Ann Emerg Med. 1993 Sep;22(9):1378-84.

PMID:
7689800
8.

Preliminary assessment of cardiac short term safety and efficacy of manganese chloride for cardiovascular magnetic resonance in humans.

Fernandes JL, Storey P, da Silva JA, de Figueiredo GS, Kalaf JM, Coelho OR.

J Cardiovasc Magn Reson. 2011 Jan 14;13:6. doi: 10.1186/1532-429X-13-6.

9.

Integrated analysis of cardiac tissue structure and function for improved identification of reversible myocardial dysfunction.

Hoffmann R, Stempel K, Kühl H, Balzer J, Krämer N, Krombach G, Kelm M, Becker M.

Coron Artery Dis. 2009 Jan;20(1):21-6. doi: 10.1097/MCA.0b013e32831040a6.

PMID:
19008764
10.

Contrast-enhanced cardiac magnetic resonance in the evaluation of myocardial infarction and myocardial viability in patients with ischemic heart disease.

Bucciarelli-Ducci C, Wu E, Lee DC, Holly TA, Klocke FJ, Bonow RO.

Curr Probl Cardiol. 2006 Feb;31(2):128-68. Review. No abstract available.

PMID:
16413381
11.

Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study.

Kwon DH, Halley CM, Carrigan TP, Zysek V, Popovic ZB, Setser R, Schoenhagen P, Starling RC, Flamm SD, Desai MY.

JACC Cardiovasc Imaging. 2009 Jan;2(1):34-44. doi: 10.1016/j.jcmg.2008.09.010.

12.

Proton nuclear magnetic resonance imaging of regionally ischemic canine hearts: effect of paramagnetic proton signal enhancement.

Brady TJ, Goldman MR, Pykett IL, Buonanno FS, Kistler JP, Newhouse JH, Burt CT, Hinshaw WS, Pohost GM.

Radiology. 1982 Jul;144(2):343-7.

PMID:
6283594
13.

In vivo nuclear magnetic resonance imaging of myocardial perfusion using the paramagnetic contrast agent manganese gluconate.

Schaefer S, Lange RA, Kulkarni PV, Katz J, Parkey RW, Willerson JT, Peshock RM.

J Am Coll Cardiol. 1989 Aug;14(2):472-80.

14.

Cardiac MRI in ischemic heart disease with severe coronary artery stenosis.

Unlu M, Anik Y, Demirci A, Ural D, Kahraman G, Komsuoglu B.

Acad Radiol. 2006 Nov;13(11):1387-93.

PMID:
17070457
15.

First-pass myocardial perfusion cardiovascular magnetic resonance at 3 Tesla.

Su MY, Yang KC, Wu CC, Wu YW, Yu HY, Tseng RY, Tseng WY.

J Cardiovasc Magn Reson. 2007;9(4):633-44.

PMID:
17578718
16.

Gd(ABE-DTTA)-enhanced cardiac MRI for the diagnosis of ischemic events in the heart.

Simor T, Gaszner B, Oshinski JN, Waldrop SM, Pettigrew RI, Horváth IG, Hild G, Elgavish GA.

J Magn Reson Imaging. 2005 May;21(5):536-45.

PMID:
15834916
17.

Multislice measurement of first-pass transit of gadobenate dimeglumine in normal and ischemic myocardium in dogs.

Sakuma H, Wendland MF, Saeed M, Derugin N, Geschwind JF, Lauerna K, Mintorovitch J, Cavagna FM, Higgins CB.

Acad Radiol. 1995 Oct;2(10):864-70.

PMID:
9419652
18.

MRI of acute myocardial ischemia: comparing a new contrast agent, Gd-DTPA-24-cascade-polymer, with Gd-DTPA.

Roberts HC, Saeed M, Roberts TP, Mühler A, Brasch RC.

J Magn Reson Imaging. 1999 Feb;9(2):204-8.

PMID:
10077014
19.

Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla.

Klumpp B, Fenchel M, Hoevelborn T, Helber U, Scheule A, Claussen C, Miller S.

Invest Radiol. 2006 Sep;41(9):661-7.

PMID:
16896300
20.

Delayed-enhancement magnetic resonance imaging at 3.0T using 0.15mmol/kg of contrast agent for the assessment of chronic myocardial infarction.

Yang J, Ma H, Liu J, Wang C, Shi Y, Xie H, Huo F, Liu F, Lin K.

Eur J Radiol. 2014 May;83(5):778-82. doi: 10.1016/j.ejrad.2014.01.012. Epub 2014 Jan 23.

PMID:
24565750
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk